For what it's worth, here are my notes of cc. Typing fast, so probably missed a few things:
August 24, 2011
FIBROCELL CC
David Pernock, CEO
Business Update
Been focused on capital raise efforts since FDA approval
$28+ M placement,
Launch: September of this year
Made available to a select no. of physicians who have been trained
Building solid, sustainable business based on good service
Doing right rather than fast
Training many physicians: 125 currently on waiting list
Training difficult (actually, not sure if he said was or was not difficult, but time consuming)
Hired excellent agencies for advertising, public relations, recruiting and training
Submitted several scientific papers for publication
Attending many conferences this year and beyond
China JV progressing well, expecting a large presence in China
Mfg: LaVive is being manufactured in their own plant in Pennsylvania
LaVive: Can be used in acne scaring, vocal scarring, periodontal and ....
L.Term Scientific collaboration at UCLA allows them to research how fibroblast cells can be changed into other functional cell types
Plan to develop other indications
In a good spot and well positioned for other uses
CFO & CEO will participate in many conferences coming up
Cannot provide more details on commercialization strategy for competitive reasons
Would not take questions